BSH Annual Scientific Meeting 2024 | BSH2024
The BSH Annual Scientific Meeting has been bringing haematology professionals together to listen, learn and network since 1960
The BSH Annual Scientific Meeting has been bringing haematology professionals together to listen, learn and network since 1960
Treatment with cilta-cel may give patients with multiple myeloma “more time,” according to Ishmael Applewhite, BSN, RN-BC, OCN.
ASH-EHA Translational Research Training in Hematology is a unique, year-long training and mentoring program focused on helping junior researchers build successful careers in hematologic translational…
Jharna M. Patel, MD, discusses the utility of ChatGPT in genetic counseling for patients with gynecologic cancers.
Sanam Loghavi and Naval Daver discuss the current approach to the diagnosis and classification, risk-stratification and treatment options for newly diagnosed AML in the context…
The benefit of early palliative care in a resource-limited setting is not well understood. This study examined whether early palliative care could improve
Frontline eftilagimod alpha plus pembrolizumab generated responses in patients with recurrent or metastatic HNSCC with negative PD-L1 expression.
Overseeing the running of all aspects of the Society’s work, our Trustees are clinical experts with many years’ experience of working across all aspects of…
Cancer Gene Therapy – Mesenchymal stem cells as therapeutic vehicles for glioma
Here, we summarize a phase II study investigating the safety and efficacy of low-dose azacitidine + venetoclax as maintenance therapy in patients with acute myeloid…